BIMI Holdings Inc. (BIMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 21, 2025
BIMI Holdings Revenue
BIMI Holdings had revenue of $2.52M in the quarter ending September 30, 2023, a decrease of -48.85%. This brings the company's revenue in the last twelve months to $12.63M, up 91.60% year-over-year. In the year 2022, BIMI Holdings had annual revenue of $11.83M, down -44.51%.
Revenue (ttm)
12.63M
Revenue Growth
+91.60%
P/S Ratio
0.00
Revenue / Employee
42.68K
Employees
296
Market Cap
1.40K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |
BIMI Holdings News
- 4 weeks ago - BIMI Pharmaceuticals (BIMI) Stock Plummets 72% in OTC Market - GuruFocus
- 8 months ago - BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq - GlobeNewsWire
- 1 year ago - BIMI Announces Results of 2023 Annual General Meeting of Stockholders - GlobeNewsWire
- 1 year ago - BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results - GlobeNewsWire
- 1 year ago - BIMI Announces Buyback of Warrants - GlobeNewsWire
- 1 year ago - BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results - GlobeNewsWire
- 1 year ago - BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire
- 1 year ago - BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch - GlobeNewsWire